Influence of donor-recipient HLA-DR matching on efficacy of anti-CD25 mAb in cardiac transplantation

Transplant Proc. 2001 Feb-Mar;33(1-2):1018. doi: 10.1016/s0041-1345(00)02311-3.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Acute Disease
  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Daclizumab
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control*
  • HLA-DR Antigens / immunology
  • Heart Transplantation / immunology*
  • Histocompatibility*
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Immunosuppressive Agents / therapeutic use*
  • Prospective Studies

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • HLA-DR Antigens
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Daclizumab